EGFR-IN-162
EGFR-IN-162 (compound 20) is a potent EGFR inhibitor. EGFR-IN-162 increases early and late apoptosis and necrosis. EGFR-IN-162 is promising for research of breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
CCCCCCCCOC(C=C1)=CC=C1N2C(COC3=CC=CC4=C3C=CC=C4)=CN=N2
Molecular Formula
C27H31N3O2
Molecular Weight
429.55
References & Citations
[1]Khalaf Alshamari, Asma, et al. Targeting EGFR Kinase Inhibitor by Novel Naphthalene-1, 2, 3-Triazole Hybrids via Click Chemistry: Synthesis, Cell-Cycle Arrest, Apoptosis, and In Silico Studies. Polycyclic Aromatic Compounds (2025) : 1-24.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680679-500 1x 500 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC050391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881830-100 1x 100 µL
CD68 (Macrophage Marker) (LAMP4/1830), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041139-500 1x 500 µL
CD66, pan (CEA) (Cocktail), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471201-500 1x 500 µL
Neurofilament (H+L) (RT-97 + NR-4), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details